{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:09:10Z","timestamp":1783613350719,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006506","name":"Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.contraception.2020.05.009","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T11:18:22Z","timestamp":1590491902000},"page":"254-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders"],"prefix":"10.1016","volume":"102","author":[{"given":"R.R.","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ba\u00eata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Silva-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.L.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2020.05.009_b0005","unstructured":"National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management, https:\/\/www.nice.org.uk\/guidance\/ng88; 2018 [accessed 02 December 2019]."},{"key":"10.1016\/j.contraception.2020.05.009_b0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2012.11.004","article-title":"Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial","volume":"87","author":"Silva-Filho","year":"2013","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2020.05.009_b0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/13625187.2018.1483018","article-title":"Heavy menstrual bleeding: a global survey of health care practitioners\u2019 perceptions","volume":"23","author":"Rocha","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"12","key":"10.1016\/j.contraception.2020.05.009_b0020","first-page":"e1","article-title":"Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel","volume":"201","author":"James","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2020.05.009_b0025","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(09)70151-3","article-title":"Von Willebrand disease in women: awareness and diagnosis","volume":"124","author":"James","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2020.05.009_b0030","unstructured":"Rocha, LF. Adapta\u00e7\u00e3o cultural e valida\u00e7\u00e3o da vers\u00e3o brasileira do question\u00e1rio de avalia\u00e7\u00e3o de sa\u00fade em esclerodermia. Tese de doutorado, Faculdade de Medicina da Universidade de S\u00e3o Paulo, https:\/\/www.teses.usp.br\/teses\/disponiveis\/5\/5164\/tde-08112013-104124\/publico\/LuizaFuocoRocha.pdf; 2013 [accessed 10 February 2020]."},{"key":"10.1016\/j.contraception.2020.05.009_b0035","unstructured":"Campolina AG, Ciconelli RM. O SF-36 e o desenvolvimento de novas medidas de avalia\u00e7\u00e3o de qualidade de vida. Acta Reumatol Port2008 Apr-Jun;33(2):127-33."},{"key":"10.1016\/j.contraception.2020.05.009_b0040","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-008833","article-title":"Levonorgestrel intrauterine system as a treatment option for severe menorrhagia in adolescent with type III von Willebrand disease","volume":"2013","author":"Silva","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.contraception.2020.05.009_b0045","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.fertnstert.2007.07.1315","article-title":"Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders","volume":"90","author":"Lukes","year":"2008","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.contraception.2020.05.009_b0050","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.2004.00176.x","article-title":"von Willebrand disease in women with menorrhagia: a systematic review","volume":"111","author":"Shankar","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2020.05.009_b0055","series-title":"Williams Gynecology","author":"Hoffman","year":"2016"},{"issue":"12","key":"10.1016\/j.contraception.2020.05.009_b0060","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1471-0528.2004.00305.x","article-title":"The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders","volume":"111","author":"Kingman","year":"2004","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.contraception.2020.05.009_b0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpag.2016.04.001","article-title":"Levonorgestrel-releasing intra-uterine device use in adolescent females with heavy menstrual bleeding and bleeding disorders: single institution review","volume":"30","author":"Oluyemisi","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2020.05.009_b0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jmig.2011.08.005","article-title":"A Systematic Review Comparing Hysterectomy with Less-Invasive Treatments for Abnormal uterine bleeding","volume":"19","author":"Matteson","year":"2012","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2020.05.009_b0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ogc.2016.04.002","article-title":"Management of Abnormal uterine bleeding with Emphasis on Alternatives to Hysterectomy","volume":"43","author":"Billow","year":"2016","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"7138","key":"10.1016\/j.contraception.2020.05.009_b0080","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1136\/bmj.316.7138.1122","article-title":"Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy","volume":"316","author":"L\u00e4hteenm\u00e4ki","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2020.05.009_b0085","unstructured":"World Health Organization. Medical eligibility criteria for contraceptive use, 5th ed., https:\/\/apps.who.int\/iris\/handle\/10665\/181468; 2015 [accessed 10 February 2020]."},{"key":"10.1016\/j.contraception.2020.05.009_b0090","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/hae.12886","article-title":"PBAC score: an easy-to-use tool to predict coagulation disorders in women with idiopathic heavy menstrual bleeding","volume":"22","author":"Halimeh","year":"2016","journal-title":"Haemophilia"},{"issue":"8","key":"10.1016\/j.contraception.2020.05.009_b0095","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.contraception.2020.05.009_b0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0004-9514(07)70033-8","article-title":"The Medical Outcomes Study 36-item short-form health survey (SF-36)","volume":"53","author":"Stwert","year":"2007","journal-title":"Aust J Physiother"},{"key":"10.1016\/j.contraception.2020.05.009_b0105","first-page":"143","article-title":"Tradu\u00e7\u00e3o para a l\u00edngua portuguesa e valida\u00e7\u00e3o do question\u00e1rio gen\u00e9rico de avalia\u00e7\u00e3o de qualidade de vida SF-36 (Brasil SF-36)","volume":"39","author":"Ciconelli","year":"1999","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.contraception.2020.05.009_b0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","article-title":"Validating the SF-36 health survey questionnaire: new outcome measure for primary care","volume":"305","author":"Brazier","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2020.05.009_b0115","series-title":"Statistics principles and methods","first-page":"578","author":"Johnson","year":"1986"},{"key":"10.1016\/j.contraception.2020.05.009_b0120","series-title":"Practical nonparametric statistics","first-page":"493","author":"Conover","year":"1980"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782420301578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782420301578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:16:44Z","timestamp":1757881004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782420301578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0010782420301578"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2020.05.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2020.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}